David A. Siegel Kaleido Biosciences, Inc. Transaction History

Two Sigma Advisers, LP

  • $41.3 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$5.36 - $7.99 $246,560 - $367,540
-46,000 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$5.82 - $8.72 $297,402 - $445,592
-51,100 Reduced 52.63%
46,000 $342,000
Q1 2021

May 17, 2021
BUY
$7.2 - $16.82 $699,120 - $1.63 Million
97,100 New
97,100 $787,000
Q4 2020

Feb 16, 2021
SELL
$5.77 - $11.33 $59,430 - $116,699
-10,300 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$5.09 - $11.07 $52,427 - $114,021
10,300 New
10,300 $114,000

Others Institutions Holding KLDO

# of Institutions
2
Shares Held
2.65K
Call Options Held
0
Put Options Held
0
View Full List

About Kaleido Biosciences, Inc.

KLDO Quotes by TradingView
  • Ticker KLDO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,622,600
  • Description
  • Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...
More about KLDO
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email